During the past decade, Krankenhaus St. Elisabeth und St. Barbara conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus St. Elisabeth und St. Barbara" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "North Eastern German Society of Gynaecological Oncology" with 2 trials sponsored, "Jena University Hospital" with 1 trials sponsored and "Karolinska University Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus St. Elisabeth und St. Barbara" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Center for Clinical Trials Philipps University Marburg" with 1 trials as a collaborator, "Clovis Oncology, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus St. Elisabeth und St. Barbara" are "Lymphoma" (3 trials), "Neuroblastoma" (2 trials), "Breast Cancer" (1 trials), "Clear Cell Carcinoma" (1 trials) and "Estrogen Receptor Positive Tumor" (1 trials). Many other conditions were trialed in "Krankenhaus St. Elisabeth und St. Barbara" in a lesser frequency.

Most popular intervention types in "Krankenhaus St. Elisabeth und St. Barbara" are "Drug" (7 trials), "Biological" (5 trials), "Radiation" (5 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "radiation therapy" (5 trials), "vincristine sulfate" (5 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus St. Elisabeth und St. Barbara" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenhaus St. Elisabeth und St. Barbara". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Krankenhaus St. Elisabeth und St. Barbara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus St. Elisabeth und St. Barbara, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".